Gastrointestinal Cancer

Trial Evaluating Nivolumab for Patients with Esophageal Cancer Meets Primary End Point of DFS
August 11, 2020
ByMatthew Fowler

Bristol Myers Squibb’s CheckMate-577 trial, which evaluated nivolumab to treat patients with resected esophageal or gastroesophageal junction cancer, met the primary end point of disease-free survival.

Effect of Lifestyle Factors and Garlic Supplementation on Gastric Cancer Incidence
July 20, 2020
ByHannah Slater

This study found that smoking was associated with an increased risk of gastric cancer incidence and mortality, while not drinking was correlated with a stronger beneficial effect of garlic supplementation on gastric cancer prevention.

Phase 2 Trial Shows Promise for Regorafenib in Pretreated Biliary Tract Cancer
July 19, 2020
ByHannah Slater

In this multi-institutional study, regorafenib demonstrated modest clinical efficacy in heavily pretreated patients with biliary tract cancer.